Treatment with an oncolytic virus and an immunostimulant for...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/39 (2006.01) A61K 31/00 (2006.01) A61K 31/7084 (2006.01) A61K 35/76 (2006.01) A61P 35/00 (2006.01) A61P 37/04 (2006.01) C07H 21/04 (2006.01) C12N 7/00 (2006.01)

Patent

CA 2621127

This invention provides novel methods of treating or alleviating neoplasms in a mammal and enhancing the efficacy of oncolytic viruses by using a combination of an oncolytic virus and an immunostimulant, comprising administering a reovirus to a host and enhancing an immune response by the addition of an immunostimulant such as a CpG oligodeoxynucleotide or at least one antigen of said virus that is delivered to a host by dendritic cells.

La présente invention concerne de nouveaux procédés permettant de traiter des néoplasmes ou de réduire leur prolifération chez un mammifère et de renforcer l~efficacité des virus oncolytiques en associant un virus oncolytique et un immunostimulant. Le traitement consiste à administrer un réovirus à un hôte et à renforcer une réponse immunitaire en ajoutant un immunostimulant tel que l~oligodéoxynucléotide CpG ou au moins un antigène dudit virus qui est transmis à un hôte par des cellules dendritiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment with an oncolytic virus and an immunostimulant for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment with an oncolytic virus and an immunostimulant for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment with an oncolytic virus and an immunostimulant for... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1724864

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.